Development and characterization of paromomycin-resistant Leishmania donovani promastigotes
Parasite, 5 2 (1998) 167-173
Published online: 2014-09-19
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar and Gurubasavaraja Swamy Purawarga MatadaEuropean Journal of Medicinal Chemistry 263 115927 (2024)
https://doi.org/10.1016/j.ejmech.2023.115927
Étude de la sélection de bactéries résistantes aux antibiotiques dans les élevages bovins ayant recours à la paromomycine contre la cryptosporidiose du veau
Romane Dubost, Clara Bourel Conroy, Frederic Lebœuf and Yves MillemannLe Nouveau Praticien Vétérinaire élevages & santé 16 (59) 80 (2024)
https://doi.org/10.1051/npvelsa/2025030
In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against Leishmania
Estela Melcón-Fernández, Giulio Galli, Rafael Balaña-Fouce, Nerea García-Fernández, María Martínez-Valladares, Rosa M. Reguera, Carlos García-Estrada and Yolanda Pérez-PertejoTropical Medicine and Infectious Disease 9 (2) 30 (2024)
https://doi.org/10.3390/tropicalmed9020030
329 (2023)
https://doi.org/10.1007/978-981-19-9605-4_16
Conventional treatments and non-PEGylated liposome encapsulated doxorubicin for visceral leishmaniasis
Soumya Ranjan Satapathy and Rudra Narayan SahooAsian Pacific Journal of Tropical Medicine 15 (7) 293 (2022)
https://doi.org/10.4103/1995-7645.348156
Why do few drug delivery systems to combat neglected tropical diseases reach the market? An analysis from the technology’s stages
Jabson Herber Profiro de Oliveira, Igor Eduardo Silva Arruda, José Izak Ribeiro de Araújo, et al.Expert Opinion on Therapeutic Patents 32 (1) 89 (2022)
https://doi.org/10.1080/13543776.2021.1970746
Leishmaniasis: where are we and where are we heading?
Santanu Sasidharan and Prakash SaudagarParasitology Research 120 (5) 1541 (2021)
https://doi.org/10.1007/s00436-021-07139-2
Experimental Selection of Paromomycin Resistance in Leishmania donovani Amastigotes Induces Variable Genomic Polymorphisms
Sarah Hendrickx, João Luís Reis-Cunha, Sarah Forrester, Daniel C. Jeffares and Guy CaljonMicroorganisms 9 (8) 1546 (2021)
https://doi.org/10.3390/microorganisms9081546
Antileishmanial Drug Discovery and Development: Time to Reset the Model?
Ana Isabel Olías-Molero, Concepción de la Fuente, Montserrat Cuquerella, Juan J. Torrado and José M. AlundaMicroorganisms 9 (12) 2500 (2021)
https://doi.org/10.3390/microorganisms9122500
Pathogenesis, Treatment and Prevention of Leishmaniasis
Vinita Gouri, Satish Chandra Pandey, Diksha Joshi, et al.Pathogenesis, Treatment and Prevention of Leishmaniasis 141 (2021)
https://doi.org/10.1016/B978-0-12-822800-5.00011-1
Targeting the Trypanothione Reductase of Tissue-Residing Leishmania in Hosts’ Reticuloendothelial System: A Flexible Water-Soluble Ferrocenylquinoline-Based Preclinical Drug Candidate
Debarati Mukherjee, Md Yousuf, Somaditya Dey, et al.Journal of Medicinal Chemistry 63 (24) 15621 (2020)
https://doi.org/10.1021/acs.jmedchem.0c00690
Metal Compounds against Neglected Tropical Diseases
Yih Ching Ong, Saonli Roy, Philip C. Andrews and Gilles GasserChemical Reviews 119 (2) 730 (2019)
https://doi.org/10.1021/acs.chemrev.8b00338
Recent Advances in the Discovery of Novel Antiprotozoal Agents
Seong-Min Lee, Min-Sun Kim, Faisal Hayat and Dongyun ShinMolecules 24 (21) 3886 (2019)
https://doi.org/10.3390/molecules24213886
Validation of NAD synthase inhibitors for inhibiting the cell viability ofLeishmania donovani:In silicoandin vitroapproach
Haraprasad Mandal, Saravanan Vijayakumar, Shalini Yadav, Shubhankar Kumar Singh and Pradeep DasJournal of Biomolecular Structure and Dynamics 37 (17) 4481 (2019)
https://doi.org/10.1080/07391102.2018.1552199
Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania
Arijit Bhattacharya, Philippe Leprohon, Sophia Bigot, et al.Nature Communications 10 (1) (2019)
https://doi.org/10.1038/s41467-019-13344-6
Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition Metals
Richard J. Wall, Sonia Moniz, Michael G. Thomas, et al.Antimicrobial Agents and Chemotherapy 62 (8) (2018)
https://doi.org/10.1128/AAC.00235-18
Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs
Anke E. Kip, Jan H. M. Schellens, Jos H. Beijnen and Thomas P. C. DorloClinical Pharmacokinetics 57 (2) 151 (2018)
https://doi.org/10.1007/s40262-017-0570-0
Drug Resistance in Leishmania Parasites
Margriet den Boer and Jorge AlvarDrug Resistance in Leishmania Parasites 145 (2018)
https://doi.org/10.1007/978-3-319-74186-4_6
Evaluating drug resistance in visceral leishmaniasis: the challenges
S HENDRICKX, PJ GUERIN, G CALJON, SL CROFT and L MAESParasitology 145 (4) 453 (2018)
https://doi.org/10.1017/S0031182016002031
Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs
Alberto Rastrojo, Raquel García-Hernández, Paola Vargas, et al.International Journal for Parasitology: Drugs and Drug Resistance 8 (2) 246 (2018)
https://doi.org/10.1016/j.ijpddr.2018.04.002
new status check test - typesetters
lina p and test twesuF1000Research 6 1110 (2017)
https://doi.org/10.12688/f1000research.20455.1
test invite referee issues 5169
lina pF1000Research 6 1108 (2017)
https://doi.org/10.12688/f1000research.20458.1
test status bar
lina p and test testF1000Research 6 1107 (2017)
https://doi.org/10.12688/f1000research.20442.1
Standard text not appearing on published blank referee reports when they are expanded
lina pF1000Research 6 1049 (2017)
https://doi.org/10.12688/f1000research.20019.2
Standard text not appearing on published blank referee reports when they are expanded
lina pF1000Research 6 1049 (2017)
https://doi.org/10.12688/f1000research.20019.1
test orcid - hopefully works
test linaWellcome Open Research 2 153 (2017)
https://doi.org/10.12688/wellcomeopenres.19709.1
faculty critique
lina pF1000Research 6 897 (2017)
https://doi.org/10.12688/f1000research.19263.1
check tracked article and gateway sumission then email
lina pF1000Research 6 1226 (2017)
https://doi.org/10.12688/f1000research.21145.1
terer
test newauthor and lina pF1000Research 6 900 (2017)
https://doi.org/10.12688/f1000research.19276.1
test article
lina pF1000Research 6 1064 (2017)
https://doi.org/10.12688/f1000research.20107.1
title update: to referee report testing
lina p, unknown unknown, unknown unknown and unknown unknownF1000Research 6 988 (2017)
https://doi.org/10.12688/f1000research.19678.1
referees and coreferees list/punctuation
lina pF1000Research 6 874 (2017)
https://doi.org/10.12688/f1000research.19187.1
A very hot morning
lina p and testtest testF1000Research 6 871 (2017)
https://doi.org/10.12688/f1000research.19169.1
dataset?
lina pF1000Research 6 851 (2017)
https://doi.org/10.12688/f1000research.19070.1
'Normal article'
lina pF1000Research 6 899 (2017)
https://doi.org/10.12688/f1000research.19265.1
test orcid id - should be sent to orcid sandbox too
linaa ppatelWellcome Open Research 2 151 (2017)
https://doi.org/10.12688/wellcomeopenres.19707.1
test article - how to cite text size new test
lina p and tete teteF1000Research 6 1013 (2017)
https://doi.org/10.12688/f1000research.19897.1
Test Article PDF doesnt update if the referees/co-referees create a orcid id
lina patelF1000Research 6 1118 (2017)
https://doi.org/10.12688/f1000research.20526.1
test - Show articles for referees suggested by editor or other referee
test testF1000Research 6 1123 (2017)
https://doi.org/10.12688/f1000research.20557.1
Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum
Sarah Hendrickx, Magali Van den Kerkhof, Dorien Mabille, et al.PLOS Neglected Tropical Diseases 11 (5) e0005620 (2017)
https://doi.org/10.1371/journal.pntd.0005620
this is a new submission via the 'referees and authors' section
lina patelWellcome Open Research 2 138 (2017)
https://doi.org/10.12688/wellcomeopenres.19477.1
Test Lina Gateway from gateway submission
lina patelWellcome Open Research 2 136 (2017)
https://doi.org/10.12688/wellcomeopenres.19475.1
test articleerrrrrrerere rrrrrr testing
lina p and test testWellcome Open Research 2 114 (2017)
https://doi.org/10.12688/wellcomeopenres.18759.1
test
test lina, test test and test testWellcome Open Research 2 154 (2017)
https://doi.org/10.12688/wellcomeopenres.19711.1
test 'normal flow with emails and referees'
lina p, Test TestAuthor and test authorF1000Research 6 1017 (2017)
https://doi.org/10.12688/f1000research.19911.1
test
test lina, test test and test testWellcome Open Research 2 154 (2017)
https://doi.org/10.12688/wellcomeopenres.19711.2
test
test lina, test test and test testWellcome Open Research 2 154 (2017)
https://doi.org/10.12688/wellcomeopenres.19711.3
test gateway through main page submission
lina pWellcome Open Research 2 137 (2017)
https://doi.org/10.12688/wellcomeopenres.19476.1
test pubmed indexed article
lina pWellcome Open Research 2 131 (2017)
https://doi.org/10.12688/wellcomeopenres.19308.1
test gateway via main page wellcome
lina pWellcome Open Research 2 130 (2017)
https://doi.org/10.12688/wellcomeopenres.19203.1
test gateway submission via wellcome gateway page
lina pWellcome Open Research 2 129 (2017)
https://doi.org/10.12688/wellcomeopenres.19202.1
A very hot morning
lina p and testtest testF1000Research 6 871 (2017)
https://doi.org/10.12688/f1000research.19169.3
A very hot morning
lina p and testtest testF1000Research 6 871 (2017)
https://doi.org/10.12688/f1000research.19169.2
Olya ORCID api2 2 Aug 2017
Olga Grytsevych, unknown unknown and Olya vF1000Research 6 1106 (2017)
https://doi.org/10.12688/f1000research.20431.2
Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress
Deepak Kumar Deep, Ruchi Singh, Vasundhra Bhandari, et al.PLOS Neglected Tropical Diseases 11 (6) e0005641 (2017)
https://doi.org/10.1371/journal.pntd.0005641
Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
Aditya Verma, Vasundhra Bhandari, Deepak Kumar Deep, et al.International Journal for Parasitology: Drugs and Drug Resistance 7 (3) 370 (2017)
https://doi.org/10.1016/j.ijpddr.2017.10.004
Antimicrobial Drug Resistance
Goutam Mandal, Vaidya Govindarajan, Mansi Sharma, Hiranmoy Bhattacharjee and Rita MukhopadhyayAntimicrobial Drug Resistance 649 (2017)
https://doi.org/10.1007/978-3-319-46718-4_42
Drug Discovery for Leishmaniasis
Annelies Mondelaers, Sarah Hendrickx, Guy Caljon and Louis MaesDrug Discovery for Leishmaniasis 371 (2017)
https://doi.org/10.1039/9781788010177-00371
Antileishmanial activity of novel indolyl–coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction
Jaiprakash N. Sangshetti, Firoz A. Kalam Khan, Abhishek A. Kulkarni, et al.Bioorganic & Medicinal Chemistry Letters 26 (3) 829 (2016)
https://doi.org/10.1016/j.bmcl.2015.12.085
Kala Azar in South Asia
Farrokh ModabberKala Azar in South Asia 79 (2016)
https://doi.org/10.1007/978-3-319-47101-3_7
Kala Azar in South Asia
Shyam Sundar and Dipti AgarwalKala Azar in South Asia 53 (2016)
https://doi.org/10.1007/978-3-319-47101-3_5
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
James S. McCarthy, Glenn W. Wortmann and Louis V. KirchhoffMandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 510 (2015)
https://doi.org/10.1016/B978-1-4557-4801-3.00041-2
In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model
S. Hendrickx, A. Mondelaers, E. Eberhardt, et al.Antimicrobial Agents and Chemotherapy 59 (8) 4714 (2015)
https://doi.org/10.1128/AAC.00707-15
Antileishmanial drug discovery: comprehensive review of the last 10 years
Jaiprakash N. Sangshetti, Firoz A. Kalam Khan, Abhishek A. Kulkarni, Rohidas Arote and Rajendra H. PatilRSC Advances 5 (41) 32376 (2015)
https://doi.org/10.1039/C5RA02669E
Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum
S. Hendrickx, G. Boulet, A. Mondelaers, et al.Parasitology Research 113 (5) 1875 (2014)
https://doi.org/10.1007/s00436-014-3835-7
Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis
M. J. Corral, D. R. Serrano, I. Moreno, et al.Journal of Antimicrobial Chemotherapy 69 (12) 3268 (2014)
https://doi.org/10.1093/jac/dku290
Elucidation of Cellular Mechanisms Involved in Experimental Paromomycin Resistance in Leishmania donovani
Vasundhra Bhandari, Shyam Sundar, Jean Claude Dujardin and Poonam SalotraAntimicrobial Agents and Chemotherapy 58 (5) 2580 (2014)
https://doi.org/10.1128/AAC.01574-13
Natural product based leads to fight against leishmaniasis
Nisha Singh, Bhuwan B. Mishra, Surabhi Bajpai, Rakesh K. Singh and Vinod K. TiwariBioorganic & Medicinal Chemistry 22 (1) 18 (2014)
https://doi.org/10.1016/j.bmc.2013.11.048
Fruitful Decade for Antileishmanial Compounds from 2002 to Late 2011
Hidayat Hussain, Ahmed Al-Harrasi, Ahmed Al-Rawahi, Ivan R. Green and Simon GibbonsChemical Reviews 114 (20) 10369 (2014)
https://doi.org/10.1021/cr400552x
17 (2013)
https://doi.org/10.1002/9783527670383.ch2
Drug Resistance in Leishmaniasis: Current Drug-Delivery Systems and Future Perspectives
Masoom Yasinzai, Momin Khan, Akhtar Nadhman and Gul ShahnazFuture Medicinal Chemistry 5 (15) 1877 (2013)
https://doi.org/10.4155/fmc.13.143
Drug Resistance in Leishmania Parasites
Margriet den Boer, Luis Rivas and Jorge AlvarDrug Resistance in Leishmania Parasites 167 (2013)
https://doi.org/10.1007/978-3-7091-1125-3_8
1 (2013)
https://doi.org/10.1002/9783527670383.ch1
Drug Resistance in Leishmania Parasites
Louis Maes, Raquel Andreia Inocencio da Luz, Paul Cos and Vanessa YardleyDrug Resistance in Leishmania Parasites 301 (2013)
https://doi.org/10.1007/978-3-7091-1125-3_15
Leishmaniasis: Current status of available drugs and new potential drug targets
Nisha Singh, Manish Kumar and Rakesh Kumar SinghAsian Pacific Journal of Tropical Medicine 5 (6) 485 (2012)
https://doi.org/10.1016/S1995-7645(12)60084-4
The stepwise selection for ketoconazole resistance induces upregulation of C14-demethylase (CYP51) in Leishmania amazonensis
Valter Viana Andrade-Neto, Herbert Leonel de Matos-Guedes, Daniel Cláudio de Oliveira Gomes, et al.Memórias do Instituto Oswaldo Cruz 107 (3) 416 (2012)
https://doi.org/10.1590/S0074-02762012000300018
Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol
Sarah Hendrickx, Raquel Andrea Inocêncio da Luz, Vasundhra Bhandari, et al.PLoS Neglected Tropical Diseases 6 (5) e1664 (2012)
https://doi.org/10.1371/journal.pntd.0001664
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
Shyam Sundar, Prabhat Kumar Sinha, Madhukar Rai, et al.The Lancet 377 (9764) 477 (2011)
https://doi.org/10.1016/S0140-6736(10)62050-8
47 (2011)
https://doi.org/10.1007/978-94-007-0277-6_6
In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB/c mice
Joshua Muli Mutiso, John Chege Macharia, Mustafa Barasa, et al.Revista do Instituto de Medicina Tropical de São Paulo 53 (3) 129 (2011)
https://doi.org/10.1590/S0036-46652011000300003
35 (2011)
https://doi.org/10.1007/978-94-007-0277-6_5
Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs
Nishi Shakya, Preeti Bajpai and Suman GuptaJournal of Parasitic Diseases 35 (2) 104 (2011)
https://doi.org/10.1007/s12639-011-0040-9
Combination therapy for visceral leishmaniasis
Johan van Griensven, Manica Balasegaram, Filip Meheus, et al.The Lancet Infectious Diseases 10 (3) 184 (2010)
https://doi.org/10.1016/S1473-3099(10)70011-6
Antimicrobial Drug Resistance
Hiranmoy Bhattacharjee and Rita MukhopadhyayAntimicrobial Drug Resistance 575 (2009)
https://doi.org/10.1007/978-1-59745-180-2_41
Developments in the treatment of visceral leishmaniasis
Margriet Leontine den Boer, Jorge Alvar, Robert N Davidson, Koert Ritmeijer and Manica BalasegaramExpert Opinion on Emerging Drugs 14 (3) 395 (2009)
https://doi.org/10.1517/14728210903153862
Paromomycin
Robert N. Davidson, Margriet den Boer and Koert RitmeijerTransactions of the Royal Society of Tropical Medicine and Hygiene 103 (7) 653 (2009)
https://doi.org/10.1016/j.trstmh.2008.09.008
Paromomycin: Uptake and resistance in Leishmania donovani
Anupam Jhingran, Bhavna Chawla, Shailendra Saxena, Michael Peter Barrett and Rentala MadhubalaMolecular and Biochemical Parasitology 164 (2) 111 (2009)
https://doi.org/10.1016/j.molbiopara.2008.12.007
Wirkstoffe zur Behandlung von Leishmaniosen. Antimon und mehr
Jasmin Ryczak and Conrad KunickPharmazie in unserer Zeit 38 (6) 538 (2009)
https://doi.org/10.1002/pauz.200900342
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
Jorge Alvar, Pilar Aparicio, Abraham Aseffa, et al.Clinical Microbiology Reviews 21 (2) 334 (2008)
https://doi.org/10.1128/CMR.00061-07
Control of Human Parasitic Diseases
Jorge Alvar, Simon Croft and Piero OlliaroAdvances in Parasitology, Control of Human Parasitic Diseases 61 223 (2006)
https://doi.org/10.1016/S0065-308X(05)61006-8
Drug Resistance in Leishmaniasis
Simon L. Croft, Shyam Sundar and Alan H. FairlambClinical Microbiology Reviews 19 (1) 111 (2006)
https://doi.org/10.1128/CMR.19.1.111-126.2006
In vitro antileishmanial activity of acetogenins from Annonaceae
S. Raynaud-Le Grandic, C. Fourneau, A. Laurens, et al.Biomedicine & Pharmacotherapy 58 (6-7) 388 (2004)
https://doi.org/10.1016/j.biopha.2004.02.007
Characterisation of atovaquone resistance in Leishmania infantum promastigotes
E Cauchetier, P.M Loiseau, J Lehman, et al.International Journal for Parasitology 32 (8) 1043 (2002)
https://doi.org/10.1016/S0020-7519(02)00065-6
Monitoring drug resistance in leishmaniasis
Simon L. CroftTropical Medicine & International Health 6 (11) 899 (2001)
https://doi.org/10.1046/j.1365-3156.2001.00754.x
Current methodologies for the analysis of aminoglycosides
David A SteadJournal of Chromatography B: Biomedical Sciences and Applications 747 (1-2) 69 (2000)
https://doi.org/10.1016/S0378-4347(00)00133-X